InterCure Ltd. (INCR)
- Previous Close
3.2900 - Open
3.3300 - Bid 3.1300 x 400
- Ask 3.2100 x 200
- Day's Range
3.1100 - 3.3300 - 52 Week Range
0.9900 - 3.7200 - Volume
48,558 - Avg. Volume
71,395 - Market Cap (intraday)
145.377M - Beta (5Y Monthly) 0.24
- PE Ratio (TTM)
-- - EPS (TTM)
-0.3700 - Earnings Date Apr 1, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
33.40
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.
www.intercure.co270
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: INCR
Performance Overview: INCR
Trailing total returns as of 5/10/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: INCR
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: INCR
Valuation Measures
Market Cap
145.38M
Enterprise Value
170.78M
Trailing P/E
15.12
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.52
Price/Book (mrq)
1.19
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-17.43%
Return on Assets (ttm)
-0.11%
Return on Equity (ttm)
-12.99%
Revenue (ttm)
355.55M
Net Income Avi to Common (ttm)
-61.96M
Diluted EPS (ttm)
-0.3700
Balance Sheet and Cash Flow
Total Cash (mrq)
101.33M
Total Debt/Equity (mrq)
42.81%
Levered Free Cash Flow (ttm)
-58.34M
Research Analysis: INCR
Company Insights: INCR
INCR does not have Company Insights